Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02538627
Title Phase 1 Combination Study of MM-151 and MM-121
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications

head and neck cancer

colorectal cancer

lung cancer

Therapies

Seribantumab

MM-151

Age Groups: adult
Covered Countries USA


No variant requirements are available.